Objective: Controversy regarding the relationship between body mass index (BMI) and mortality continues to exist. Most of the previous studies have not comprehensively accounted for major sources of bias. We examined the association between BMI and all-cause mortality according to pre-existing disease and smoking status in a large prospective cohort. Methods: Participants were 99 253 male physicians in the Physicians' Health Study enrollment cohort (40-84 years) who provided self-reported information in 1982. We used Cox proportional hazards regression to examine the association between baseline BMI and mortality. Results: A total of 5438 men died (median follow-up, 5.7 years). Although a U-shaped association between BMI and all-cause mortality was seen among all men, we found a linear relationship when accounting for potential sources of bias. In the optimal model excluding men who died within 2 years, and adjusting for age, smoking, alcohol consumption, physical activity, prior disease and interactions between BMI and prior disease, and between BMI and smoking, those with BMI o20.0 kg/m 2 had a relative risk (RR) of death of 0.88 (95% confidence interval (CI), 0.56-1.40), as compared to men with BMI 22.5-24.9 kg/m 2 . By contrast, men with BMI 30.0-34.9 kg/m 2 had an RR of 1.45 (95% CI, 1.10-1.91) and those with BMI X35.0 kg/m 2 had an RR of 1.62 (95% CI, 1.12-2.35; P for linear trend, o0.001). According to WHO categories, men in the 'overweight' range (BMI 25.0-29.9 kg/m 2 ) had an RR of 1.20 (95% CI, 1.05-1.38) as compared to men in the 'normal' range (BMI o25.0 kg/m 2 ). Conclusions: In this large, prospective cohort, we found a consistent linear association between higher BMI and increased risk of mortality after accounting for several potential sources of bias, even among those within the 'overweight' range of BMI. Public health messages should emphasize the preponderance of evidence supporting the adverse health effects associated with higher body weight.
Introduction
Overweight and obesity remain growing public health concerns. Among US adults, approximately 65% are overweight or obese (body mass index (BMI), X25.0 kg/m 2 ), and more than 30% are obese (BMI X30 kg/m 2 ). 1 Estimated costs attributable to overweight and obesity have reached over 9% of total annual US medical expenditures. 2 Multiple studies have documented adverse health consequences of overweight and obesity, including increased risks of diabetes, 3 hypertension, 4 chronic kidney disease, 5 stroke, 6 coronary heart disease 7-9 and cancer. 10 Despite extensive investigations, however, controversy regarding the relationship between BMI and mortality continues to exist. Prior studies suggesting U-or J-shaped associations have often not comprehensively accounted for potential sources of confounding, with underestimates of the effect of overweight and obesity on longevity and overestimates of the risks of leanness. Major potential sources of bias particular to studies of BMI and mortality include (1) failure to account adequately for confounding by cigarette smoking, (2) inappropriate adjustment for the biological effects of obesity, including hypertension and diabetes and (3) failure to account adequately for confounding due to pre-existing diseases. 11 Findings from our study cohort have previously shown that higher BMI is associated with increased mortality among men without known prior disease. 12 As in other studies of women, 13, 14 BMI and mortality were linearly related when adjusting for multiple potential confounders and excluding smokers and those with early deaths possibly due to pre-existing disease. 12 In the current study, we extend prior findings to demonstrate how estimates of J-or Ushaped associations may be obtained without careful analytical consideration of potential sources of bias. We therefore examined the association between BMI and mortality according to pre-existing disease and smoking status in a large prospective cohort of more than 99 000 US male physicians.
Methods

Study population
The Physicians' Health Study (PHS) was a randomized trial of aspirin and beta-carotene in the primary prevention of cardiovascular disease and cancer in 22 071 male physicians. The design, methods and results of the PHS have been described in detail elsewhere. [15] [16] [17] ). These men include 22 054 of the 22 071 respondents subsequently randomized into the trial as well as non-randomized respondents. . Self-reports of weight and height have been validated in other health professional cohorts and shown to be highly accurate (Spearman r ¼ 0.97 in the Nurses' Health Study and r ¼ 0.97 in the Health Professionals Followup Study, as compared to measured weights). 18 
Assessment of BMI
Outcomes
We identified deaths through systematic searches of the National Death Index (NDI). We identified cohort members who died before 1 February, 1988 and obtained their death certificates from state agencies. Trained nosologists classified causes of death according to the International Classification of Diseases -Ninth Revision (ICD-9) in conjunction with the 'Automated Classification of Medical Entities Decision Tables' to select the underlying cause of death. We examined all-cause mortality as our primary outcome. Secondary analyses included as outcomes cardiovascular-related mortality (ICD-9 codes 390-459, including sudden death, ICD-9 code 798.2), cancer-related mortality (ICD-9 codes 140-239) and all other deaths. The reliability of the NDI for epidemiological purposes among health professionals has been previously validated. 19 Statistical analysis All analyses were performed using SAS Software Version 9.1 (SAS Institute, Cary, NC, USA). We compared baseline characteristics according to BMI categories by w 2 -tests for categorical variables and analysis of variance for continuous variables. We used Cox proportional hazards models to compute relative risks (RRs) and 95% confidence intervals (CIs) of mortality for various classifications of BMI.
Multivariable-adjusted models accounted for baseline age (continuous, in years), alcohol consumption (rare/never, 1-3 drinks/month, 1-6 drinks/week, X1 drink/day) and physical activity (rare/never, 1 time/month, 1 time/week, 2-4 times/ week, 44 times/week). We performed several analyses to demonstrate the contribution of other sources of bias, considering subgroups according to smoking status (never, past or current at baseline), pre-existing disease (yes/no; defined as self-reported history of myocardial infarction, stroke, cancer or liver disease) and unmeasured or subclinical disease manifested by early deaths (o/42 years of follow-up).
To demonstrate the aggregate confounding introduced by these factors, we also analyzed men with 42 years of followup, adjusting for the same set of variables as mentioned above, as well as smoking (never (referent group), past, current), prior disease (no (referent group), yes), interactions between smoking history (any/never) and baseline BMI (six categories) and interactions between prior disease (yes/no) and baseline BMI (six categories). This model assumes no interaction other than that between smoking and BMI and between prior disease and BMI. This approach has the advantage of greater power to detect associations between BMI and mortality as compared to an analysis that excludes persons with a history of smoking or prior disease. The RRs shown apply to the men without a history of smoking or known prior disease. We compared results from this 'optimal' model with those from a 'confounded' model that included only men with any smoking history, known prior disease or p2 years of follow-up. Including age as a quadratic term did not improve the overall fit of this 'optimal' model, as determined by the likelihood ratio test (LRT) contrasting models with age as a linear versus quadratic term (P-value ¼ 0.38).
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We assessed for linear and curvilinear trends in the RR of mortality by assigning BMI categories their median values, including BMI in the models as a continuous, linear term or as a quadratic variable, respectively, and comparing models using the LRT. To assess for effect modification, we used the LRT contrasting age-adjusted models with and without interaction terms for baseline BMI in six categories with smoking history at baseline (any/never) and with history of pre-existing disease (yes/no).
Results
Characteristics of the 99 253 participants are shown according to baseline BMI in Table 1 . As expected, men with higher BMI were significantly more likely to report a history of hypertension, diabetes and high cholesterol. They also consumed less alcohol and were less physically active. Men with BMI o20.0 kg/m 2 were most likely to smoke at baseline and to have known pre-existing disease. Among 99 253 men, 5438 died during a median follow-up of 5.7 years (including 2701 deaths due to cardiovascular disease, 1608 deaths due to cancer and 1129 deaths due to other causes; maximum follow-up, 6.6 years). In analyses of all men, adjusting only for age, alcohol consumption and physical activity, a U-shaped association was found between baseline BMI and all-cause mortality ( Table 2 ). The highest mortality occurred among the leanest men (BMI o20.0 kg/m 2 ), with an RR of 1.68 (95% CI, 1.45-1.93), as compared to the referent group with BMI 22.5-24.9 kg/m 2 (P comparing linear and curvilinear trends, o0.001).
In analyses stratified by smoking history, U-shaped associations between BMI and all-cause mortality were also seen, with an increased risk among the leanest men being most pronounced among men who were current smokers at baseline, followed by those with a past smoking history (P for the interaction between BMI and smoking, 0.01; Figure 1 ). Among never smokers, by contrast, the RR of mortality was highest among obese men (RR, 1.39; 95% CI, 1.13-1.71 for BMI X30.0 kg/m 2 ; Table 3 ). In subgroup analyses according to prior disease, mortality among the leanest men was similarly increased as compared to the referent group, both for men with and without known pre-existing disease ( Figure 1 ). However, obese men without prior disease had a higher RR of death, whereas obese men with known prior disease had an attenuated RR of death (P for the interaction between BMI and prior disease ¼ 0.02). The multivariable-adjusted RR of mortality among obese men without prior disease was 1.57 (95% CI, 1.36-1.82) as compared to 1.08 (95% CI, 0.90-1.29) among those with prior disease, relative to the respective referent groups (BMI 22.5-24.9 kg/m 2 ; Table 4 ). To demonstrate the aggregate confounding due to smoking, pre-existing disease and unmeasured disease reflected in early deaths, we analyzed men with either a smoking history (current or past, including those missing smoking information), known pre-existing disease or p2 years of follow-up (those who died or were censored during the first 2 years) as a 'biased' subgroup (Table 5 ). Men in the leanest BMI category had the highest RR of mortality as compared to men in the referent group (BMI 22.5-24.9 kg/m 2 ). In analyses adjusted for age, alcohol consumption and physical activity, the RR of mortality among the leanest men was 1.68 (95% CI, Body mass index and mortality RP Gelber et al 1.45-1.95), whereas the RR was 1.27 (95% CI, 1.13-1.44) among obese men ('confounded model,' Table 5 and Figure 2 ). By contrast, a linear association was found using an 'optimal model' analyzing all men with 42 years of followup and adjusting for smoking, pre-existing disease and their interactions with BMI, in addition to age, alcohol consumption and physical activity. Higher baseline BMI was associated with increased mortality across all BMI categories. Evaluating the main effects of BMI from this model (corresponding to men without prior disease or any smoking history), the RR for mortality among the leanest men was 0.88 (95% CI, 0.56-1.40) as compared to 1.45 (95% CI, 1.10- ) had an RR of 1.46 (95% CI, 1.12-1.91) and those with class II-III obesity (BMI X35.0) had an RR of 1.62 (95% CI, 1.12-2.35) when using the 'optimal model' and main effects for BMI (P comparing linear and curvilinear trends, 0.30).
Secondary analyses of cause-specific mortality demonstrated similar U-shaped associations between BMI and mortality when not fully accounting for potential confounding. In the 'biased' subgroup (as defined above), the leanest men again had the highest risk of cancer-and cardiovascular- Adjusts for baseline age (continuous, in years), alcohol consumption (rare/never, 1-3 drinks/month, 1-6 drinks/week, X1 drink/day) and physical activity (rare/never, 1 time/month-1 time/week, 2-4 times/week, 44 times/week). Adjusts for baseline age (continuous, in years), alcohol consumption (rare/never, 1-3 drinks/month, 1-6 drinks/week, X1 drink/day) and physical activity (rare/never, 1 time/month-1 time/week, 2-4 times/week, 44 times/week). By contrast, we again found linear associations between BMI and cause-specific mortality using the 'optimal model.' Evaluating the main effects of BMI from this model, the RR (95% CI) for cancer-related mortality was 0.41 (0.12- 
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Discussion
In this large, prospective cohort of men, we found a consistent linear association between BMI and increased risk of mortality after accounting for several potential sources of confounding. Although a U-shaped association between BMI and mortality was seen among all men, we found a 
Relative Risk
Men without prior disease
Men with prior disease Figure 1 RR and 95% CIs for all-cause mortality according to BMI at baseline, smoking status and prior disease. Models for all figures adjust for baseline age (continuous, in years), alcohol consumption (rare/never, 1-3 drinks/month, 1-6 drinks/week, X1 drink/day) and physical activity (rare/ never, 1 time/month -1 time/week, 2-4 times/week, 44 times/week). Prior disease defined as self-reported history of myocardial infarction, stroke, cancer or liver disease. b Adjusts for baseline age (continuous, in years), alcohol consumption (rare/never, 1-3 drinks/month, 1-6 drinks/week, X1 drink/day) and physical activity (rare/never, 1 time/month-1 time/week, 2-4 times/week, 44 times/week).
Body mass index and mortality RP Gelber et al monotonically increasing association after accounting for pre-existing disease, smoking and early deaths. The increased mortality among the lean in the entire study cohort was primarily due to the subgroups with smoking history and known pre-existing disease. In addition, inadequate accounting for these sources of confounding attenuated the risk of mortality among obese men as compared to the risk among the lean. This biased risk among the obese was primarily seen among men who had pre-existing disease. As expected, excluding individuals with early deaths and accounting for smoking, prior disease and their interactions with BMI in an 'optimal model' led to higher risk estimates among the obese and appropriately diminished the risk among the lean (Table 2 ). Our findings emphasize the importance of adequately considering these potential sources of bias in studies of BMI and mortality.
Our study confirms findings from prior investigations that have shown direct, monotonic associations between BMI and mortality. 12, 13, 20, 21 Manson et al. 11, 13 previously demonstrated the importance of considering smoking, pre-existing disease, illness-related weight loss and early deaths as a marker of subclinical or unmeasured disease. In analyses of the PHS enrollment cohort limited to individuals without known pre-existing disease, higher BMI was linearly associated with increased mortality among men who never smoked. 12 Furthermore, in a study of men with a history of cardiovascular disease, leanness was associated with higher mortality, 22 similar to our findings of men with pre-existing disease.
In another cohort of US male health professionals without pre-existing disease, J-shaped associations between BMI and all-cause mortality were found after excluding those who died in the first 4 years of follow-up or who had substantial recent weight loss at study entry, with linear associations found among men o65 years only. 23 However, these analyses did not exclude men with a smoking history or account for interactions between BMI and smoking. In the Cancer Prevention Study II, mortality was increased among the lean (BMI o22.0 kg/m 2 ) relative to the referent group (BMI 23.5-24.9 kg/m 2 ), even after exclusion of smokers and Biased subgroup includes only men with pre-existing disease (myocardial infarction, cancer, stroke or liver disease), smoking history (current or past, including those missing smoking information) or p2 years of follow-up.
b Confounded model adjusts for baseline age (continuous, in years), alcohol consumption (rare/never, 1-3 drinks/month, 1-6 drinks/week, X1 drink/day) and physical activity (rare/never, 1 time/month-1 time/week, 2-4 times/week, 44 times/week). Optimal model excludes men with p2 years of follow-up and adjusts for the covariates described above plus smoking status (never, past, current), prior disease status (yes/no), interactions between smoking status (any/never) and baseline BMI (six categories), and interactions between prior disease status (yes/no) and baseline BMI (six categories). Relative risks (RR) shown are from the main effects of BMI in the model, corresponding to the men without any smoking history or prior disease. Figure 2 RR and 95% CIs for all-cause mortality according to BMI at baseline. Confounded model includes only men with smoking history (prior or current), self-reported pre-existing disease (history of myocardial infarction, stroke, cancer or liver disease) or those with p2 years of follow-up, and adjusts for baseline age (continuous, in years), alcohol consumption (rare/never, 1-3 drinks/month, 1-6 drinks/week, X1 drink/day) and physical activity (rare/ never, 1 time/month-1 time/week, 2-4 times/week, 44 times/week). Optimal model includes all men with 42 years of follow-up and adjusts for the same variables as the 'confounded model', plus smoking (never, past, current), prior disease (yes/no), interactions between smoking (any/never) and baseline BMI (six categories) and interactions between prior disease (yes/ no) and baseline BMI (six categories). RRs shown are from the main effects of BMI in the model, corresponding to the RR for men without any smoking history or prior disease.
those with a history of pre-existing disease. 24 However, while these analyses accounted for individuals with early weight loss, participants with early deaths were not excluded, and analyses did not account for interactions between BMI and smoking or prior disease. As in our study and others, 11, 13 the authors demonstrated modification of the association between BMI and mortality by smoking and prior disease. As reviewed elsewhere, 11, 25 previous studies suggesting Ushaped, J-shaped or inverse associations between BMI and mortality [26] [27] [28] [29] [30] have generally not comprehensively accounted for major potential sources of bias. A few studies have emphasized a lack of increased mortality among those who are overweight 27 -a potentially precarious public health message in the setting of the growing prevalence of overweight and obesity.
Our study extends the current understanding of the association between BMI and mortality to demonstrate how careful analytical considerations may address the potential for biased estimates of increased mortality among lean individuals, and attenuated risk among the obese, seen in other studies. We accounted for major potential sources of bias by excluding individuals with early deaths and by incorporating the effect of interactions between BMI and prior disease, and between BMI and smoking in our models. Compared to approaches that exclude participants who smoke or who have prior disease, our approach assumes no interaction other than that between BMI and smoking, and between BMI and prior disease, and has the advantage of increased power due to the larger sample size.
Additional strengths of our study include the large number of participants and events, the prospective design and a comprehensive ascertainment of participant characteristics at baseline. However, certain limitations should be considered.
Our study included only US male physicians, the majority of whom were white, which may limit generalizability of our findings. However, the homogeneity of our study population reduces possible confounding by educational attainment and socioeconomic status. Furthermore, we do not expect that the underlying relationship between adiposity and mortality should be considerably altered among other races. Although some studies suggest that associations between BMI and mortality may be modified by race and sex, with black women particularly having an attenuated risk of death associated with higher BMI, 24 such findings may be due in part to misclassification if BMI less adequately reflects adiposity in certain racial groups. Alternatively, this attenuated risk may also be related to residual confounding rather than to underlying differences in the biological effects of obesity. Secondly, we used self-reported weight and height to assess BMI. However, validation studies of other health professional cohorts have demonstrated the reliability of selfreported information on height, weight and cardiovascular risk factors.
18,31 Moreover, we expect that BMI misclassification might result from underestimation of weight at higher BMI levels and overestimation at lower levels, 32 such that potential misclassification of BMI would likely yield an underestimate of effect. Thirdly, we had no information on waist or hip circumference, which may provide complementary information on adiposity and be more predictive of mortality than BMI. 33 We were also not able, with our design, to exclude individuals with a history of recent weight loss. A history of weight loss may represent subclinical disease, such that increased mortality among leaner individuals may be related to underlying disease and potentially bias estimates of the association between BMI and mortality. 11 However, we expect that such unmeasured weight loss would have resulted in underestimates of the risk of mortality.
In conclusion, we found a linear association between BMI and risk of death, even among those within the 'overweight' range of BMI, without increased risk among the lean. Our study confirms others indicating that overweight and obesity increase the risk of mortality among otherwise healthy individuals. Furthermore, our findings emphasize the need to account appropriately for potential sources of bias. Public health messages should emphasize the preponderance of evidence supporting adverse health effects associated with higher body weight.
